Healthcare Purchasing News
  • Magazine
  • Continuing Education
  • Webinars
  • Whitepapers
  • Videos
  • Events
  • Hall of Fame
  • Advertise
  • Source Guide
  • Subscribe
  • Sourcing & Logistics
  • Sterile Processing
  • Surgical & Critical Care
  • Patient Satisfaction
  • Infection Prevention
  • EVS & Facility Services
  • Healthcare IT
  • Regulatory
  • Topics
    Sourcing & LogisticsSterile ProcessingSurgical & Critical CarePatient SatisfactionInfection PreventionEVS & Facility ServicesHealthcare ITRegulatory
    Resources
    HPN Source GuideContinuing EducationWebinarsWhitepapersVideosEventsHall of FameAdvertiseAd Specs
    User Tools
    SubscribeContact UsAbout UseNewsletterMagazinesPrivacy PolicyTerms & Conditions
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    1. Surgical/Critical Care

    AHIP comments on CMS’ approach for covering Alzheimer’s disease treatments

    Feb. 11, 2022
    https://pixabay.com/users/tumisu-148124/
    Mental Health G411aadfaa 1920

    In comments submitted by AHIP, a national association whose members provide healthcare coverage, to the Centers for Medicare & Medicaid Services (CMS) regarding the Proposed National Coverage Determination (NCD) for Monoclonal Antibodies (mAbs) Directed Against Amyloid for the Treatment of Alzheimer’s Disease, AHIP reaffirmed its commitment saying that Alzheimer’s disease takes a heavy toll on patients and their families.

    The comments say that AHIP strongly supports CMS’ proposed approach to coverage of these treatments in the context of clinical trials:

    “We commend CMS for its comprehensive, thoughtful and objective analysis of the clinical evidence, benefits, and potential side effects of this class of therapies. We agree with CMS’ conclusion that ‘no trial has been able to demonstrate any meaningful improvement in patient health outcomes,’ noting: ‘Due to the lack of a clear clinical benefit and the frequency of adverse events like [amyloid related imaging abnormalities] ARIA, the evidence does not support that the benefits outweigh the harms for mAbs directed against amyloid for the treatment of AD.’”

    This is the right approach for patients:

    “The proposed NCD is the right approach for patients. It would provide Medicare patients consistent and national access for this class of products and related services. And it would appropriately emphasize the need for sufficient clinical evidence to support future determinations of whether these drugs are both reasonable and necessary for the right populations within the program.”

    It is also important that CMS would require that clinical trials for these treatments reflect the diversity of the population with Alzheimer’s Disease.

    Many stakeholders agree with CMS’ approach:

    “CMS and many clinicians, health systems, and other stakeholders recognize that Medicare coverage should apply only when there is clear evidence of clinical benefit to patients that outweighs the risk of significant harm, and they have appropriately concluded there is not sufficient evidence on safety and effectiveness to meet this standard.”

    AHIP release

    Latest in Surgical/Critical Care

    Photo 59932819 © Monkey Business Images | Dreamstime.com
    Surgical/Critical Care

    CSI Academy Teams to Focus on Implementing HWE Standards

    Nov. 29, 2023
    621037713 © LAYHONG| stock.adobe.com
    Surgical/Critical Care

    Horizon-scanning next-generation surgical beds, tables, exam chairs

    Rick Dana Barlow
    Nov. 28, 2023
    Photo 170837495 © Thanee Hengpattanapong | Dreamstime.com
    Surgical/Critical Care

    FDA: Do Not Use Cardinal Health Monoject Syringes with Syringe Pumps and PCA Pumps

    Nov. 27, 2023
    Photo 27013405 © Hongqi Zhang (aka Michael Zhang) | Dreamstime.com
    Surgical/Critical Care

    The 3 Pillars to Reduce Healthcare Drug Diversion Among Nurses with Substance Use Disorder

    Deborah Koivula RN, BSN, CARN
    Nov. 20, 2023
    Photo 165865963 © Andrew Norris | Dreamstime.com
    Surgical/Critical Care

    FDA issues letter to healthcare providers about labeling updates for BD surgical mesh products

    Nov. 15, 2023
    Healthcare Purchasing News
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    • About Us
    • Contact Us
    • Advertise
    • Do Not Sell or Share
    • Privacy Policy
    • Terms & Conditions
    © 2023 Endeavor Business Media, LLC. All rights reserved.
    Endeavor Business Media Logo